DEA Archived Press Releases

Press Releases before January 20, 2025
402 Results - Showing 361 to 370
PRESS RELEASE

DEA Announces 19th National Prescription Drug Take Back Day

OMAHA, Neb.— The Drug Enforcement Administration (DEA) is holding its 19 th National Prescription Drug Take Back Day Saturday, October 24, at multiple locations across the country including more than 200 sites within the five state Omaha Division comprised of Iowa, Minnesota, Nebraska, North Dakota and South Dakota. The annual...
PRESS RELEASE

City of Chicago skyline lit red in support of Red Ribbon Week and DEA’s 19th National Prescription Drug Take Back Day on October 24, 2020

CHICAGO – Robert J. Bell, Special Agent in Charge (SAC) of the Drug Enforcement Administration (DEA) Chicago Division, announces the Red Ribbon Celebration during the week of October 23-31, which coincides with DEA’s 19 th National Prescription Drug Take Back Day on October 24, 2020. Red Ribbon Week raises awareness...
PRESS RELEASE

DEA announces 19th National Prescription Drug Take Back Day

BOSTON – DEA is holding its 19th National Prescription Drug Take Back Day on Saturday, Oct. 24 at locations across the country. The nationwide event aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse...
PRESS RELEASE

DEA announces 19th National Prescription Drug Take Back Day

WASHINGTON – DEA is holding its 19th National Prescription Drug Take Back Day on Saturday, Oct. 24 at locations across the country. The nationwide event aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse...
PRESS RELEASE

DEA announces 19th National Prescription Drug Take Back Day

HOUSTON – DEA is holding its 19th National Prescription Drug Take Back Day on Saturday, Oct. 24 at locations across the country. The nationwide event aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse...
PRESS RELEASE

DEA announces 19th National Prescription Drug Take Back Day

WASHINGTON – DEA is holding its 19th National Prescription Drug Take Back Day on Saturday, Oct. 24 at locations across the country. The nationwide event aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse...
PRESS RELEASE

DEA announces 19th National Prescription Drug Take Back Day

NEW YORK CITY – DEA is holding its 19th National Prescription Drug Take Back Day on Saturday, Oct. 24 at locations across the country. The nationwide event aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential...
PRESS RELEASE

DEA Implements Ecommerce Outreach Program to Combat Counterfeit Drug Production

WASHINGTON – The U.S. Drug Enforcement Administration has developed an e-commerce outreach program aimed at reducing the availability of dangerous, often deadly, counterfeit prescription drugs in the United States. This DEA-led initiative focuses on educating online retailers about the sale of pill presses and components used in the production of...
PRESS RELEASE

DEA St. Louis Division launches website for community resources

ST. LOUIS – Unintended consequences of social distancing and isolation throughout the COVID-19 pandemic can include increased substance use, experimentation and even relapse for those in treatment and recovery. To help people find support facilities, the Drug Enforcement Administration St. Louis Division, along with community partners, has launched a website...
PRESS RELEASE

Omnicare Inc. agrees to pay more than $15 million to resolve allegations it improperly dispensed narcotics at long-term care facilities

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...